Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs

Time:2024-01-31 / View:263 times

Prev: Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis

Next: Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis

Back